A bipartisan bill introduced in the U.S. House of Representatives would eliminate the upcoming Medicare physician payment cut.
Editor’s note: APMA submitted comments to CMS in response to proposed changes to the Medicare Physician Fee Schedule and the Quality Payment Program in 2023.
Microemulsion Technology provides Podiatrists with better penetration and better results. With small particle size Formula 7®’s antibacterial and antifungal properties deliver the benefit of multiple products in a single tube or jar. The leader in Tolfnaftate Technology since 1986! Formula 7®is the first tolnaftate microemulsion utilizing soluble tolnaftate, the technology developed by the Tetra Corporation.
Power Diary now includes a complete Practice Operations Manual providing a set of policies and procedures that practices can configure to meet their businesses' needs, set standards for the workplace, and maintain professional operations. Developed by a team with over 50 years of industry experience, this game-changing feature is available exclusively to all Power Diary customers!
